Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Clinical Pharmacology

Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series

Journal of the American Academy of Dermatology | Mar 19, 2020 Clinical Pharmacology

Risk of tuberculosis reactivation during interleukin‐17 inhibitor therapy for psoriasis: A systematic review

Journal of the European Academy of Dermatology and Venereology | Mar 19, 2020 Clinical Pharmacology

Statins may reduce disease recurrence in patients with ulcerated primary melanoma

British Journal of Dermatology | Mar 09, 2020 Clinical Pharmacology

Changes in list prices, net prices, and discounts for branded drugs in the US, 2007-2018

JAMA | Mar 08, 2020 Clinical Pharmacology

Drug survival of adalimumab, ustekinumab, and secukinumab in patients with psoriasis: A prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

British Journal of Dermatology | Mar 06, 2020 Clinical Pharmacology

Efficacy and safety of lebrikizumab, a high-affinity interleukin 13 inhibitor, in adults with moderate to severe atopic dermatitis: A phase 2b randomized clinical trial

JAMA | Mar 02, 2020 Clinical Pharmacology

Apremilast in combination with narrowband UVB in the treatment of vitiligo: A 52-week monocentric prospective randomized placebo-controlled study

Journal of Investigative Dermatology | Feb 29, 2020 Clinical Pharmacology

Trial of nemolizumab in moderate-to-severe prurigo nodularis

New England Journal of Medicine | Feb 27, 2020 Clinical Pharmacology

Daily emollient during infancy for prevention of eczema: The BEEP randomised controlled trial

The Lancet | Feb 27, 2020 Clinical Pharmacology

Association of herpes zoster and chronic inflammatory skin disease in US inpatients

Journal of the American Academy of Dermatology | Feb 25, 2020 Clinical Pharmacology

« Prev 1 … 35 36 37 38 39 … 92 Next »

Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series

Risk of tuberculosis reactivation during interleukin‐17 inhibitor therapy for psoriasis: A systematic review

Statins may reduce disease recurrence in patients with ulcerated primary melanoma

Changes in list prices, net prices, and discounts for branded drugs in the US, 2007-2018

Drug survival of adalimumab, ustekinumab, and secukinumab in patients with psoriasis: A prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

Efficacy and safety of lebrikizumab, a high-affinity interleukin 13 inhibitor, in adults with moderate to severe atopic dermatitis: A phase 2b randomized clinical trial

Apremilast in combination with narrowband UVB in the treatment of vitiligo: A 52-week monocentric prospective randomized placebo-controlled study

Trial of nemolizumab in moderate-to-severe prurigo nodularis

Daily emollient during infancy for prevention of eczema: The BEEP randomised controlled trial

Association of herpes zoster and chronic inflammatory skin disease in US inpatients

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

MD Clip on Pulmonary Hypertension Symptoms and Management with Dr Waseem

New research aims to transform treatments of aggressive blood cancer

Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series

Risk of tuberculosis reactivation during interleukin‐17 inhibitor therapy for psoriasis: A systematic review

Statins may reduce disease recurrence in patients with ulcerated primary melanoma

Changes in list prices, net prices, and discounts for branded drugs in the US, 2007-2018

Drug survival of adalimumab, ustekinumab, and secukinumab in patients with psoriasis: A prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

Efficacy and safety of lebrikizumab, a high-affinity interleukin 13 inhibitor, in adults with moderate to severe atopic dermatitis: A phase 2b randomized clinical trial

Apremilast in combination with narrowband UVB in the treatment of vitiligo: A 52-week monocentric prospective randomized placebo-controlled study

Trial of nemolizumab in moderate-to-severe prurigo nodularis

Daily emollient during infancy for prevention of eczema: The BEEP randomised controlled trial

Association of herpes zoster and chronic inflammatory skin disease in US inpatients

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

MD Clip on Pulmonary Hypertension Symptoms and Management with Dr Waseem

New research aims to transform treatments of aggressive blood cancer

Select Specialty

Select Topic